In this study, we found that the ablation of Trappc9 resulted in disruption of systemic glucose homeostasis, which was associated with hyperinsulinemia, hyperleptinemia, hyperprolactinemia, dyslipidemia, adipocyte hypertrophy, and glucose metabolism reprogramming and lipid accumulation in the liver. This evidence concerns the gene TRAPPC9 and hyperinsulinism.